Indian Generics Makers Set To Produce Tamiflu For Patent-Free Nations
This article was originally published in PharmAsia News
Executive Summary
India's drug makers are receiving requests from several countries to supply a generic version of Roche's Tamiflu (oseltamivir) antiviral against the spreading H1N1 flu virus. A Cipla official says it alone has proposals from at least three countries to supply 1.5 million doses of the drug. Indian generics makers are free to produce the drug and ship it to countries where Roche does not have patent protection. India's patent office rejected a Roche application for protection that would have prevented production. (Click here for more